Oncology 101: The Fundamentals of Cancer ā¢ Topic 6 of 6
0/60 min0% complete
ā Back to Modules
Oncology 101: The Fundamentals of Cancer
A comprehensive overview of the basic principles of oncology, from the biology of cancer to treatment modalities.
Part 12: Knowledge Check
Test your understanding of oncology fundamentals
1. What is the major risk factor for developing lung cancer?
Category: Risk Factors | Type: Single Choice
2. What are the major risk factors for developing liver cancer?
Category: Risk Factors | Type: Single Choice
3. What are the major risk factors for developing breast cancer?
Category: Risk Factors | Type: Single Choice
4. How is cancer best defined?
Category: Basic Concepts | Type: Single Choice
5. Name the major types of cancer
Category: Basic Concepts | Type: Single Choice
6. One way cancer cells differ from normal cells is metabolism. What effect is this phenomena known as?
Category: Hallmarks | Type: Single Choice
7. Cancer cells differ from normal cells as they are able to up-regulate signals to attenuate CD-8+ T Cell proliferation. What ligand do tumor cells up-regulate?
Category: Hallmarks | Type: Single Choice
8. One way cancer cells differ from normal cells is that cancer cells can become immortal. Which enzyme do cancer cells use to elongate telomeres?
Category: Hallmarks | Type: Single Choice
9. Typically, a cancer cell can over-express a gene that contributes to tumor cell proliferation and tumor formation. This gene is known as ________
Category: Genetics | Type: Single Choice
10. Genes that are found to be deleted or mutationally inactivated in cancers and allow them to grow are called ______________ .
Category: Genetics | Type: Single Choice
11. Which of the following are key steps in metastasis?
Category: Metastasis | Type: Multiple Choice
12. Adjuvant therapy:
Category: Treatment | Type: Single Choice
13. The first line therapy for metastatic prostate cancer is:
Category: Treatment | Type: Single Choice
14. Bevacizumab (AvastinĀ®) inhibits:
Category: Treatment | Type: Single Choice
15. The two checkpoints currently targeted by immunotherapy are:
Category: Treatment | Type: Single Choice